Jorge A Carrasquillo

9PUBLICATIONS
48CO-AUTHORS
Pharmaceutical delivery technologiesHaematological tumoursInstruments and techniquesAutoimmunityGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 19, 2025
Phase II Study of 177Lu-DOTATATE for Progressive Metastatic Pheochromocytomas and Paragangliomas: Interim Analysis of Efficacy, Safety, and Biomarkers.

Frank I Lin, Jaydira Del Rivero, Jorge A Carrasquillo

|Dec 14, 2023
Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement.

David Taïeb, Svenja Nölting, Nancy D Perrier

|Mar 05, 2022
Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab.

Todd L Rosenblat, Michael R McDevitt, Jorge A Carrasquillo

|Jul 20, 2021
Monitoring Immune Activation with Whole-Body Fluorodeoxyglucose-Positron-Emission Tomography in Simian Immunodeficiency Virus-Infected Rhesus Macaques.

Sanhita Sinharay, Sharat Srinivasula, William Schreiber-Stainthorp

|Mar 09, 2021
High-Specific-Activity-131I-MIBG versus 177Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma.

Abhishek Jha, David Taïeb, Jorge A Carrasquillo

|Oct 29, 2020
B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study.

Shakeel Modak, Pat Zanzonico, Milan Grkovski

Pageof 2

Frequent Collaborators

3 joint publications

Abhishek Jha

2 joint publications

Karel Pacak

2 joint publications

Jason S Lewis

2 joint publications

Neeta Pandit-Taskar